foster nexthaler 200 micrograme/6 micrograme
chiesi farmaceutici s.p.a. - italia - combinatii (beclometasonum+formoterolum) - pulb. de inhal. - 200micrograme/6micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
foster 200 micrograme/6 micrograme
chiesi farmaceutici s.p.a. - italia - combinatii (beclometasonum+formoterolum) - sol. de inhalat presurizata - 200micrograme/6micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
tantum verde spray 1,5 mg/ml
angelini acraf spa - italia - benzydaminum - spray bucofaringian - 0,15% - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale
glimbax 0,074 g/100 ml
doppel farmaceutici s.r.l. - italia - diclofenacum - apa de gura - 0,074g/100ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale
tantum verde 1,5 mg/ml
aziende chimiche riunite angelini francesco - italia - benzydaminum - sol. pt. gargarisme - 1,5mg/ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionat, fumarat de formoterol dihidrat, bromura de glicopironiu - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
povidon-iod 100 mg/ml soluţie cutanată
guangdong kelun pharmaceutical co., ltd - povidoni iodidum - soluţie cutanată - 100 mg/ml
povidon-iod 100 mg/ml soluţie cutanată
guangdong kelun pharmaceutical co., ltd - povidoni iodidum - soluţie cutanată - 100 mg/ml
povidon-iod 100 mg/ml soluţie cutanată
guangdong kelun pharmaceutical co., ltd - povidoni iodidum - soluţie cutanată - 100 mg/ml
povidon-iod 100 mg/ml soluţie cutanată
guangdong kelun pharmaceutical co., ltd - povidoni iodidum - soluţie cutanată - 100 mg/ml